Filter posts

The Perfect Close

With a fast and furious finish, yesterday, March 2nd, the Nasdaq Composite (IXIC) closed at …

Choose Wisely My Friend- Survey Says, Identifying the Right R&D Partner is the Most Challenging Aspe...

A recent survey conducted by BIO confirms the increasing reliance on R&D outsourcing as biotech and pharmaceutical companies indicate speed, flexibility, …

Don’t Go At It Alone- BIO BizLink and the Evolving R&D Marketplace

With companies in the biotechnology industry more frequently outsourcing R&D pipelines, selecting the right contract …

BIO Investor Forum Closing Plenary: How Fragile is the Biotech Rally After Five Positive Years?

Last week’s 13th Annual BIO Investor Forum closed on Wednesday with a plenary session asking, …

Biotech CEOs Talk JOBS Act and IPO Experiences at 2014 BIO Investor Forum

The JOBS Act has contributed to a dramatic acceleration in new biotech IPOs since its …

NCATS SBIR Announces Funding For Biotechs and Small Business Technology Development

The NIH National Center for Advancing Translational Sciences (NCATS) is seeking qualified applicants for its …

Virtual Resources: BIO BizLink Meets the C&EN Online Trade Show

For those who may not have heard, BIO recently launched a new initiative: BIO BizLink. …

Maximize Your Savings and Winning Potential during the BIO International Convention

$135,000,000. That’s how much BIO saved life science companies in aggregate on their 2013 purchases …

San Francisco Business Times: Two JOBS Acts are better than one

Today, the San Francisco Business Times published an op-ed by OncoMed President and CEO Paul Hastings lauding …

SBIR Funds Speed the Delivery of Breakthrough Treatments and Cures

Today, BIO’s Executive Vice President of Emerging Companies Cartier Esham presented testimony to the U.S. …